Dow Up0.03% Nasdaq Up0.22%

AMAG Pharmaceuticals, Inc. (AMAG)

-NasdaqGS
31.67 Down 0.02(0.06%) 2:19PM EDT - Nasdaq Real Time Price
CompetitorsGet Competitors for:
Direct Competitor Comparison 
AMAGACTPVT1PVT2Industry
Market Cap:695.41M62.45BN/AN/A154.00M
Employees:14819,200N/A32,7911148.00
Qtrly Rev Growth (yoy):0.260.34N/AN/A0.05
Revenue (ttm): 88.96M10.11BN/A9.67B145.01M
Gross Margin (ttm):0.730.54N/AN/A0.54
EBITDA (ttm):-4.57M2.87BN/AN/A-3.15M
Operating Margin (ttm): -0.060.13N/AN/A0.02
Net Income (ttm):-12.45M62.40MN/A641.00M1N/A
EPS (ttm):-0.570.38N/AN/A-0.13
P/E (ttm):N/A620.29N/AN/A35.71
PEG (5 yr expected):-0.740.91N/AN/A1.32
P/S (ttm):7.826.23N/AN/A5.76
 
ACT = Actavis plc
Pvt1 = Bayer Pharma AG (privately held)
Pvt2 = DAIICHI SANKYO COMPANY, LIMITED
Industry = Diagnostic Substances
1 = As of 2014  

Biotechnology Companies Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN137.58-0.01104.57B21.08
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB321.29-0.0175.82B35.72
Genzyme CorporationPrivate - View Profile
Merck Serono S.A.Private - View Profile
Gilead Sciences Inc.GILD105.04-0.01158.56B23.76
MedImmune, L.L.C.Private - View Profile
Life Technologies CorporationPrivate - View Profile
Teva Pharmaceutical Industries LimitedTEVA54.270.0246.35B17.88
Sandoz International GmbHPrivate - View Profile
 
View Diagnostic Substances Industry Center

Generic Drugmakers Ranked by Sales 
CompanySymbolPriceChangeMarket CapP/E
Actavis plcACT236.94-0.0162.45B620.29
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL46.850.0317.54B31.91
Pfizer Inc.PFE29.05-0.00184.11B18.24
Johnson & JohnsonJNJ103.94-0.00293.07B19.21
GlaxoSmithKline plcGSK45.68-0.00109.58B14.50
SanofiSNY54.95-0.02144.23B27.88
Novartis AGNVS92.97-0.00225.76B23.63
Roche Holding AGRHHBY36.46-0.01247.74B22.29
AstraZeneca PLCAZN69.36-0.0287.60B43.27
 
View Diagnostic Substances Industry Center

Drugmakers Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Abbott LaboratoriesABT41.230.0062.03B26.84
Bristol-Myers Squibb CompanyBMY50.23-0.0183.33B31.22
 
View Diagnostic Substances Industry Center

 
News on Direct Competitors 

Currency in USD.